Can Wegovy cause gas and bloating — and what can you do about it?

What the trial data and official guidance actually show about gas on semaglutide

The clearest place to start is the evidence itself. The STEP 1 trial (a 68-week randomised study of semaglutide 2.4 mg published in the New England Journal of Medicine) found that gastrointestinal adverse events were the most frequently reported side effects, occurring in the majority of participants on active treatment. Flatulence was among the GI effects recorded alongside nausea, vomiting, diarrhoea, constipation and burping. The NHS medicines page for semaglutide lists flatulence and burping explicitly as common side effects of Wegovy, meaning they affect at least 1 in 100 people using it in practice.

One misconception worth gently setting aside: some people assume that gas on Wegovy means the medicine is not working, or that it signals something has gone wrong. It doesn't. Gas is a direct downstream effect of how semaglutide changes the digestive process, not a sign of harm, and our page on whether Wegovy can cause weight gain explores a similar theme of separating normal side effects from signs that treatment is off track. Understanding why it happens tends to reduce anxiety about it considerably.

The pattern across both trial data and clinical experience is consistent: symptoms are most pronounced when treatment begins and when the dose increases, then commonly improve within one to two weeks. Serious or persistent GI symptoms are different and worth discussing with your prescriber, but everyday wind in the early weeks is an expected part of how most people's bodies respond.

Why Wegovy slows digestion, and how that leads to gas

Semaglutide is a GLP-1 receptor agonist. Among its several effects, it slows gastric emptying: food leaves the stomach more gradually than it would otherwise. That slower transit gives gut bacteria more time to ferment carbohydrates and produce gas, and it means more air gets trapped in the upper GI tract, leading to burping and bloating alongside flatulence lower down.

This mechanism also explains the timing pattern. The starter dose of Wegovy is 0.25 mg, a level chosen to let the body adjust before the dose is increased by the prescriber; the maintenance doses are higher and the gastric-emptying effect is more pronounced at them. Each step up can bring a brief reappearance of gas symptoms that then settles again.

For a fuller look at how semaglutide works as a treatment, including the appetite and blood-sugar effects that sit alongside the gastric-emptying mechanism, our overview covers it in detail. People who are curious about the broader range of reported Wegovy effects can also explore our page on what Wegovy is known to cause, which looks at both common and less common effects across the trial data.

Practical steps that tend to reduce gas on Wegovy

There is no official NHS protocol for managing Wegovy-related gas specifically, but the general advice for GI side effects of semaglutide is well-established. Eating smaller portions more slowly is consistently the most effective single change, the medicine is already slowing how quickly food moves through, so large meals compound the backlog. Taking time to chew thoroughly before swallowing also reduces the volume of air ingested with food.

Certain foods are reliably gas-promoting: pulses, cruciferous vegetables such as broccoli and cabbage, onions, fizzy drinks, and high-fibre foods eaten in large quantities. None of these need to be avoided entirely, but reducing them during the first weeks of a new dose often helps. Carbonated drinks specifically tend to worsen belching because of the additional gas load they bring into an already-slowed system.

Eating upright, not lying down, and leaving a gap before strenuous activity after meals are simple habits that can make a difference. If you are wondering whether cost is a barrier to starting treatment and working through the early adjustment period, our Wegovy pricing guide explains exactly what a private prescription through a regulated pharmacy includes, so there are no surprises.

When gas signals something worth discussing with your prescriber

For most people, gas on Wegovy is uncomfortable rather than alarming, and it resolves with time and modest dietary adjustment. There are, though, situations where symptoms warrant a clinical conversation sooner rather than later. Persistent or severe abdominal pain (particularly pain that radiates to the back, with or without vomiting) should prompt urgent medical attention. The MHRA's January 2026 Drug Safety Update for GLP-1 medicines highlighted acute pancreatitis as a known but infrequent serious side effect; severe, persistent stomach pain is the key symptom to act on promptly.

Symptoms that do not improve after two to three weeks at a stable dose, or that are severe enough to affect eating, drinking or daily life, are worth raising with your prescriber rather than waiting. Dose adjustments or a slower titration schedule can sometimes make a significant difference to tolerability. You can report any suspected side effects, including unexpectedly severe GI reactions, through the MHRA Yellow Card scheme.

Semaglutide is not the only GLP-1 option with a distinct gut-effect profile; if you are curious how it compares with tirzepatide in terms of GI side effects and tolerability, our page on semaglutide and gas more broadly covers both medicines in that context. And if you have questions about other reported side effects entirely, the page on Wegovy and erectile dysfunction shows how the evidence is assessed for effects that patients sometimes ask about but rarely see addressed clearly.

If you want to talk through whether Wegovy is the right fit for you given your health history (including any concerns about GI tolerance) check your eligibility with our prescribers. It costs nothing, and a real clinician reads every consultation the same day.